squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• A Phase II Study of MRG003 Injection Combined With Pucotenlimab Injection ± Cisplatin Injection in the Neoadjuvant Treatment Locally Advanced EGFR-positive Head and Neck Squamous Cell Carcinoma#303720ClinicalTrials.gov
• Correlation Between the Efficacy of Neoadjuvant Chemotherapy Combined With Immunotherapy of Operable Thoracic Esophageal Squamous Cell Carcinoma and the Metabolites of Intestinal Flora#640552ClinicalTrials.gov
• Stage IV Lung Squamous Cell Carcinoma Treated With or Without Bronchial Artery Chemoembolization After First-line Chemotherapy and Immunotherapy#640568ClinicalTrials.gov
• Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma#835382ClinicalTrials.gov
• Cabazitaxel - PF Induction Chemotherapy#837121ClinicalTrials.gov
• Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery#828229ClinicalTrials.gov
• Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy#813618ClinicalTrials.gov
• Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine#454035ClinicalTrials.gov
• Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab#369832ClinicalTrials.gov
• S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors#804927ClinicalTrials.gov
• Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma#896679ClinicalTrials.gov
• Research progress on the compositional characteristics of the tumor immune microenvironment and immunopredictive models in esophageal squamous cell carcinoma#4567Europe PMC
• Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options#26277HAL (France)
• Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629#126710HAL (France)
• Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma#226243ClinicalTrials.gov
• Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors#411401ClinicalTrials.gov
• Five-year outcomes of transoral robotic surgery with or without neoadjuvant chemotherapy in laryngeal squamous cell carcinoma: a preliminary experience#823177IRIS
• Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients#844720ClinicalTrials.gov
• Cetuximab + Avelumab or Avelumab Alone for Unresectable, Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (SCCAC) Progressed After at Least One Line of Systemic Treatment (CARACAS)#869728ClinicalTrials.gov
• T-cell Based Immunotherapy for Head and Neck Cancer#172295ClinicalTrials.gov
• SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma#226238ClinicalTrials.gov
• Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinoma#868891ClinicalTrials.gov
• Quantifying Systemic Immunosuppression to Personalize Cancer Therapy#861951ClinicalTrials.gov
• Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer#826951ClinicalTrials.gov
• Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers#136328ClinicalTrials.gov
• Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial#833679ClinicalTrials.gov
• Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.#883744ClinicalTrials.gov
• Immunotherapy for early-stage cutaneous squamous cell carcinoma.#239768NCBI PubMed Central
• CIETAI and Sequential Radiotherapy in Squamous Lung Cancer#249602ClinicalTrials.gov
• Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma#272333ClinicalTrials.gov
• Identification of Key Blood Molecular Markers for Immunotherapy#363601ClinicalTrials.gov
• Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC#417562ClinicalTrials.gov
• Neoadjuvant Imiquimod Immunotherapy for Oral Cancer#651235ClinicalTrials.gov
• A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck#891148ClinicalTrials.gov
• Data-driven prognostic factors analysis and personalized follow-up strategies for post-progression survival in locally advanced esophageal squamous cell carcinoma after definitive chemoradiotherapy.#9740PubMed
• Development and validation of an interpretable Random Forest model for predicting recurrence after endoscopic submucosal dissection in superficial oesophageal squamous cell carcinoma.#9745PubMed
• Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC#307453ClinicalTrials.gov
• Peritumoral bone changes in mandibular gingival squamous cell carcinoma: A prospective radiologic-histopathologic correlation study#654946S-Space: Seoul National University
• Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging#802500ClinicalTrials.gov
• Tislelizumab Combined With Chemotherapy for Different Cycles of Neoadjuvant Therapy for Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck (NeoTempo)#807182ClinicalTrials.gov
• Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck#841819ClinicalTrials.gov
• Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck#859537ClinicalTrials.gov
• Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer#879556ClinicalTrials.gov
• Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma#889787ClinicalTrials.gov
• Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer#825481ClinicalTrials.gov
• Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer#417558ClinicalTrials.gov
• Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer#868480ClinicalTrials.gov
• CemiplimAb Survivorship Epidemiology#870793ClinicalTrials.gov
• The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC#862490ClinicalTrials.gov
• A Phase II Study of Anti-EGFR Antibody-drug Conjugate (ADC) Combine With CDK4/6 Inhibitors Posterior Line in the Treatment of Recurrent/Metastatic CDKN2A Gene Variant Head and Neck Squamous Cell Carcinoma#813932ClinicalTrials.gov